We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Marrone (MBII) Expands the Existing Inventory Line of Credit
Read MoreHide Full Article
Marrone Bio Innovations Inc. recently announced the expansion of its existing inventory line of credit to support projections for growth in sales and manufacturing capacity. It can access a maximum of $4.5 million to fund inventory needs, up from $3 million under a prior deal per an amended agreement with LSQ Funding Group, L.C.
Marrone stated that the increase in the line of credit for inventory provides it with greater flexibility to support commercial expansion in the near future. This is important as the company enters the peak selling season in North American markets to ensure it has the ability to provide customers with ready access to its products when they need them.
Shares of Marrone have declined 41.5% in the past year against a 7.3% rise of the industry.
Image Source: Zacks Investment Research
Marrone, in its last earnings call, stated that it expects revenue growth in the low double-digit to mid-teens range for 2021, factoring in the uncertainties in the agricultural markets. MBII continues to expect its product mix to deliver annual gross margins in the upper 50% range. It also expects operating expenses in line with 2020 levels, plus inflation.
Zacks Rank & Key Picks
Marrone currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks worth considering in the basic materials space include Albemarle Corporation (ALB - Free Report) , Commercial Metals Company (CMC - Free Report) and AdvanSix Inc. (ASIX - Free Report) .
Albemarle, currently carrying a Zacks Rank #2 (Buy), has an expected earnings growth rate of 49.8% for the current year. The Zacks Consensus Estimate for ALB's current-year earnings has been revised 9.2% upward in the past 60 days. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Albemarle beat the Zacks Consensus Estimate for earnings in each of the trailing four quarters, the average being 22.1%. ALB has rallied around 33.2% in a year.
Commercial Metals, flaunting a Zacks Rank #1, has a projected earnings growth rate of 10.5% for the current fiscal year. CMC's consensus estimate for the current fiscal year has been revised 6.6% upward in the past 60 days.
Commercial Metals beat the Zacks Consensus Estimate for earnings in three of the last four quarters while missing the same once. It has a trailing four-quarter earnings surprise of roughly 7.4%, on average. CMC has rallied around 64.4% in a year.
AdvanSix has a projected earnings growth rate of 3.9% for the current year. The Zacks Consensus Estimate for ASIX’s earnings for the current year has been revised 1.6% upward in the past 60 days.
AdvanSix beat the Zacks Consensus Estimate for earnings in each of the trailing four quarters, the average being 46.9%. ASIX has rallied 105.8% in a year. It currently carries a Zacks Rank #2.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Marrone (MBII) Expands the Existing Inventory Line of Credit
Marrone Bio Innovations Inc. recently announced the expansion of its existing inventory line of credit to support projections for growth in sales and manufacturing capacity. It can access a maximum of $4.5 million to fund inventory needs, up from $3 million under a prior deal per an amended agreement with LSQ Funding Group, L.C.
Marrone stated that the increase in the line of credit for inventory provides it with greater flexibility to support commercial expansion in the near future. This is important as the company enters the peak selling season in North American markets to ensure it has the ability to provide customers with ready access to its products when they need them.
Shares of Marrone have declined 41.5% in the past year against a 7.3% rise of the industry.
Marrone, in its last earnings call, stated that it expects revenue growth in the low double-digit to mid-teens range for 2021, factoring in the uncertainties in the agricultural markets. MBII continues to expect its product mix to deliver annual gross margins in the upper 50% range. It also expects operating expenses in line with 2020 levels, plus inflation.
Zacks Rank & Key Picks
Marrone currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks worth considering in the basic materials space include Albemarle Corporation (ALB - Free Report) , Commercial Metals Company (CMC - Free Report) and AdvanSix Inc. (ASIX - Free Report) .
Albemarle, currently carrying a Zacks Rank #2 (Buy), has an expected earnings growth rate of 49.8% for the current year. The Zacks Consensus Estimate for ALB's current-year earnings has been revised 9.2% upward in the past 60 days. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Albemarle beat the Zacks Consensus Estimate for earnings in each of the trailing four quarters, the average being 22.1%. ALB has rallied around 33.2% in a year.
Commercial Metals, flaunting a Zacks Rank #1, has a projected earnings growth rate of 10.5% for the current fiscal year. CMC's consensus estimate for the current fiscal year has been revised 6.6% upward in the past 60 days.
Commercial Metals beat the Zacks Consensus Estimate for earnings in three of the last four quarters while missing the same once. It has a trailing four-quarter earnings surprise of roughly 7.4%, on average. CMC has rallied around 64.4% in a year.
AdvanSix has a projected earnings growth rate of 3.9% for the current year. The Zacks Consensus Estimate for ASIX’s earnings for the current year has been revised 1.6% upward in the past 60 days.
AdvanSix beat the Zacks Consensus Estimate for earnings in each of the trailing four quarters, the average being 46.9%. ASIX has rallied 105.8% in a year. It currently carries a Zacks Rank #2.